What is your stock symbol? Our common stock is listed on the Nasdaq Global Select Market under the symbol “MYGN”. How can I buy Myriad Genetics stock? You. A high-level overview of Myriad Genetics, Inc. (MYGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. After Hours: $ (%) ; In the news. avia-mig.ru Canada. 2 days ago. Insider Sale: Director Heinrich Dreismann Sells Shares of Myriad Genetics Inc . View the latest Myriad Genetics Inc. (MYGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Myriad Genetics Inc MYGN ; Valuation · Price/Earnings (Normalized). , , ; Financial Strength · Quick Ratio. , , ; Profitability · Return.
Myriad Genetics Inc (MYGN) ; Price/Sales ; Price/Cash Flow N/A ; Price/Book ; Price/Earnings ttm ; Most Recent Earnings $ on 05/07/ Myriad Genetics traded at $ this Tuesday September 10th, decreasing $ or percent since the previous trading session. Looking back, over the last. Myriad Genetics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Find the latest historical data for Myriad Genetics, Inc. Common Stock (MYGN) at avia-mig.ru View historical data in a monthly, bi-annual, or yearly format. Myriad Genetics (MYGN) - Develops molecular diagnostic products that analyze genes and their mutations to assess the risk of cancer ; Thermo Fisher Scientific. Real-time Price Updates for Myriad Genetics Inc (MYGN-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Research Myriad Genetics' (Nasdaq:MYGN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Myriad Genetics, Inc. ; Dec, Initiated, Wolfe Research, Outperform, $28 ; Jul, Resumed, JP Morgan, Underweight, $ Myriad Genetics, Inc. is a molecular diagnostic company, which focuses on developing and marketing of novel predictive and personalized medicines and. The current price of MYGN is USD — it has increased by % in the past 24 hours. Watch Myriad Genetics, Inc. stock price performance more closely on the.
Myriad Genetics Reports Strong Second Quarter Financial Results, including 15% Revenue Growth Year-Over-Year; Raises Financial Guidance and. Myriad Genetics stock plummets 39% after lower-than-expected earnings, FDA questions. Shares of molecular-diagnostics firm Myriad Genetics Inc. plummeted 39%. Discover real-time Myriad Genetics, Inc. Common Stock (MYGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and. Myriad Genetics Inc MYGN:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/29/24 · 52 Week Low Myriad Genetics Stock Forecast FAQ. Is Myriad Genetics Stock a good buy in , according to Wall Street analysts? The consensus among 6 Wall Street analysts. Myriad Genetics hereditary cancer, prenatal, oncology and mental health genetic testing insights can help detect, treat and prevent disease. Stock analysis for Myriad Genetics Inc (MYGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests.
What is Myriad Genetics Inc(MYGN)'s stock price today? The current price of MYGN is $ The 52 week high of MYGN is $ and 52 week low is $ When. 21 minutes ago. MYGN - Myriad Genetics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Myriad Genetics Inc. ; Volume, K ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Myriad Genetics Plummets as Earnings Trail Forecasts, Guidance Is Slashed. Quarterly earnings greatly trail analysts' forecasts and Myriad Genetics sharply.
MYGN Myriad Genetics · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss. In depth view into MYGN (Myriad Genetics) stock including the latest price, news, dividend history, earnings information and financials. MYGN Stock Performance ; Previous close, ; Day range, 26 - ; Year range, 13 - 28 ; Market cap, 2,,, ; Primary exchange, NASDAQ. Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics. According to 10 analysts, the average rating for MYGN stock is "Buy." The month stock price forecast is $, which is a decrease of % from the latest.